EXHIBIT 32


     In connection with the quarterly report of EFT BioTech Holdings, Inc., (the
"Company")  on Form 10-Q for the quarter  ended  December 31, 2010 as filed with
the  Securities  and  Exchange  Commission  (the  "Report")  Jack Jie  Qin,  the
Principal  Executive and Principal  Financial Officer of the Company,  certifies
pursuant  to 18 U.S.C.  Sec.  1350,  as adopted  pursuant  to Section 906 of the
Sarbanes-Oxley Act of 2002, that:



(1)   The Report  fully  complies  with the  requirements  of Section  13(a) or
      15(d) of the Securities Exchange Act of 1934; and

(2)   The information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      company.


 February 9, 2011                         /s/ Jack Jie Qin
                                          ------------------------------
                                          Jack Jie Qin, Principal Executive and
                                          Financial Officer